Royalty Pharma plc Annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from 2018 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Royalty Pharma plc annual/quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from 2018 to 2024.
- Royalty Pharma plc Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2024 was $79M, a 4.38% decline year-over-year.
- Royalty Pharma plc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $160M, a 5.67% decline from 2023.
- Royalty Pharma plc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $169M, a 0.57% decline from 2022.
- Royalty Pharma plc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $170M, a 30.4% increase from 2021.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Growth (%)